Please log in for more information
For biopharmaceutical formulators, the complexity and natural propensity of proteins to aggregate pose a real challenge at every stage of development. As a pioneer in the industrial development of hydroxypropyl-β-cyclodextrin and polyols, Roquette provides stabilization solutions for biologic drug development.
Our latest innovation, KLEPTOSE® BioPharma HPB & HP (hydroxypropyl-β-cyclodextrin) for protein stabilization, brings established excipients for small molecule applications to the biopharma formulation community by offering plant derived, multi-compendial grade formulation excipients and cell culture media components of the highest quality that are low endotoxin.
These products are supported by a vertically integrated and fiber-free supply chain, produced in a state-of-the-art facility (US FDA and ICH Q7 GMP compliant) with a tightly controlled process delivering highly reproducible and defined material, with reduced batch-to-batch variability.
Anchored by technical expertise, Roquette is a premier solutions partner for improving stability of therapeutic proteins. To support innovation, we’ve recently expanded our R&D and Customer Technical Service teams to Singapore’s Biopolis international R&D center, where our experts partner with customers on new innovations and help solve existing formulation challenges.